MedTrace Logo

Treatment Preference and Patient Centered Prostate Cancer Care

NCT02032550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 743

Last updated 2020-08-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of treatment preferences, type of treatment received and their relationship with health related quality of life, satisfaction with care, decision regret, and psychological health of men with localized prostate cancer.

Conditions

Interventions

OTHER

Preference Based Decision Aid

The objective of the preference based decision aid is to assess the treatment preferences of prostate cancer patients. The investigators will analyze the association between preferences, treatment choice and objective and subjective outcomes. The preference based decision aid will lead to a values-based patient centered treatment decision making. This will ultimately improve clinical decision making, clinical policy process, enhance patient centered care and improve prostate cancer outcomes.

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Corporal Michael J. Crescenz VA Medical Center

    collaborator FED

  • Fox Chase Cancer Center

    collaborator OTHER

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Ravishankar Jayadevappa, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2018-01-26
Completion
2018-01-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032550 on ClinicalTrials.gov